FDA Sets Date for Advisory Committee Review of OraSure Over-the-Counter Rapid HIV Test

OraSure Technologies

today announced that the U.S. Food and Drug Administration Blood Products Advisory Committee will consider the Company's application for the approval of its OraQuick Rapid HIV-1/2 test for sale in the U.S. consumer or over-the-counter market at a meeting scheduled for May 15, 2012.